Cytokine Storm: Clinical Trials

3 trials for Cytokine Storm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown, 1 withdrawn. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 1, Unknown 1, Withdrawn 1

Follow Cytokine Storm: new trials by email Literature Review of Cytokine Storm trials Research Report on Cytokine Storm

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cytokine Guided Risk Stratification and Treatment in Pediatric Hemophagocytic Lymphohistiocytosis
Dexamethasone, Etoposide, Ruxolitinib - Hemophagocytic Lymphohistiocytoses, Cytokine Storm
Phase 4UnknownThe Children's Hospital of Zhejiang University School of Medicine4002022-09-012022-10-06
High-Dose Corticosteroid or Tocilizumab for Clinical Worsening of COVID-19
Methylprednisolone, Tocilizumab - COVID-19 Virus Infection, Cytokine Storm
Phase 4WithdrawnMarmara University2021-02-012021-11-24
Fluoxetine to Reduce Intubation and Death After COVID19 Infection
Fluoxetine - COVID-19, Cytokine Storm
Phase 4CompletedUniversity of Toledo Health Science Campus162020-05-012024-06-07

Narrower conditions

Cytokine Release Syndrome (3)  ·  COVID-19 (2)  ·  Lymphohistiocytosis, Hemophagocytic (1)

Broader conditions

Inflammation (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Shock (3)  ·  Systemic Inflammatory Response Syndrome (3)  ·  Coronaviridae Infections (2)  ·  Coronavirus Infections (2)  ·  Infections (2)  ·  Lung Diseases (2)  ·  Nidovirales Infections (2)  ·  Pneumonia (2)  ·  Pneumonia, Viral (2)  ·  RNA Virus Infections (2)  ·  Respiratory Tract Diseases (2)  ·  Respiratory Tract Infections (2)

Interventions

Adrenal Cortex Hormones (2)  ·  Dexamethasone (1)  ·  Etoposide (1)  ·  Fluoxetine (1)  ·  Methylprednisolone (1)  ·  Steroids (1)  ·  ruxolitinib (1)  ·  tocilizumab (1)

Sponsors

Marmara University (1)  ·  The Children's Hospital of Zhejiang University School of Medicine (1)  ·  University of Toledo Health Science Campus (1)

Countries

China (1)  ·  United States (1)

Top investigators

Ruslan Abdullayev (1)  ·  Xiaojun Xu, MD (1)  ·  Yongmin Tang, MD (1)